Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors

Endocrine

Volumn 56, Issue 2, 2017, Pages 298-307

  Tripodi, Armando ^a,b   Ammollo, Concetta T ^c   Semeraro, Fabrizio ^c   Colucci, Mario ^c   Malchiodi, Elena ^a,b,d   Verrua, Elisa ^a,b,d   Ferrante, Emanuele ^a,b,d   Arnaldi, Giorgio ^e   Trementino, Laura ^e   Padovan, Lidia ^a,b   Chantarangkul, Veena ^a,b   Peyvandi, Flora ^a,b   Mantovani, Giovanna ^a,b,d  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d Unit of Endocrinology   (Italy)

^e OSPEDALI RIUNITI   (Italy)

Author keywords

Activated partial thromboplastin time; Antithrombin; Factor VIII; Myeloperoxidase; Plasma DNA; Protein C; Thrombomodulin; Thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; CELL FREE DNA; CORTICOTROPIN; DNA; FIBRINOGEN; HYDROCORTISONE; MYELOPEROXIDASE; PROTEIN C; PROTHROMBIN; THROMBIN; THROMBOMODULIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; F8 PROTEIN, HUMAN;

ADULT; AGE; ARTICLE; ASSAY; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; ENDOGENOUS THROMBIN POTENTIAL RATIO; EXTRACELLULAR TRAP; FEMALE; GENDER; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPERCOAGULABILITY; MALE; NEUTROPHIL COUNT; NUCLEOSOME; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBIN GENERATION ASSAY; BLOOD; BLOOD CLOTTING TEST; METABOLISM; NEUTROPHIL;

ADRENOCORTICOTROPIC HORMONE; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; EXTRACELLULAR TRAPS; FACTOR VIII; FEMALE; HUMANS; NEUTROPHILS; PITUITARY ACTH HYPERSECRETION; PROTEIN C; THROMBIN;

EID: 84979503564     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-016-1027-1     Document Type: Article

References (47)

1. L.K. Nieman, B.M. Biller, J.W. Findling, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526–40 (2008)
2. G. Arnaldi, A. Angeli, A.B. Atkinson, X. Bertagna, F. Cavagnini, G.P. Chrousos, G.A. Fava, J.W. Findling, R.C. Gaillard, A.B. Grossman, B. Kola, A. Lacroix, T. Mancini, F. Mantero, J. Newell-Price, L.K. Nieman, N. Sonino, M.L. Vance, A. Giustina, M. Boscaro, Diagnosis and complications of Cushing’s syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593–560 (2003)
3. M. Boscaro, G. Arnaldi, Approach to the patient with possible Cushing’s syndrome. J. Clin. Endocrinol. Metab. 94, 3121–31 (2009)
4. A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community based study in Banbary (Oxfordshire, UK). Clin. Endocrinol. 72, 377–382 (2010)
5. R.N. Clayton, D. Raskauskiene, R.C. Reulen, P.W. Jones, Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK. J. Clin. Endocrinol. Metab. 96, 632–42 (2011)
6. M.J. Bolland, I.M. Holdaway, J.E. Berkeley, S. Lim, W.J. Dransfield, J.V. Conaglen, M.S. Croxson, G.D. Gamble, P.J. Hunt, R.J. Toomath, Mortality and morbidity in Cushing’s syndrome in New Zealand. Clin. Endocrinol. 75, 436–442 (2011)
7. O.M. Dekkers, N.R. Biermasz, A.M. Pereira, F. Roelfsema, M.O. van Aken, J.H. Voormolen, J.A. Romijn, Mortality in patients treated for Cushing’s disease is increased compared with patients treated for nonfunctioning pituitary macroadenoma. J. Clin. Endocrinol. Metab. 92, 976–981 (2007)
8. G. Arnaldi, T. Mancini, G. Tirabassi, L. Trementino, M. Boscaro, Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications. J. Endocrinol. Invest. 35, 434–448 (2012)
9. M. Zilio, L. Mazzai, M.T. Sartori, M. Barbot, F. Ceccato, V. Daidone, A. Casonato, G. Saggiorato, F. Noventa, L. Trementino, P. Prandoni, M. Boscaro, G. Arnaldi, C. Scaroni, A venous thromboembolism risk assessment model for patients with Cushing’s syndrome. Endocrine 52(2), 322–332 (2016)
10. L. Trementino, G. Arnaldi, G. Appolloni, V. Daidone, C. Scaroni, A. Casonato, M. Boscaro, Coagulopathy in Cushing’s syndrome. Neuroendocrinology 92(Suppl 1), 55–9 (2012). doi:10.1159/000314349
11. M. Boscaro, N. Sonino, A. Scarda, L. Barzon, F. Fallo, M.T. Sartori, G.M. Patrassi, A. Girolami, Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing’s syndrome. J. Clin. Endocrinol. Metab. 87, 3662–3666 (2002)
12. D.J.F. Stuijver, B. van Zaane, R.A. Feelders, J. Debeij, S.C. Cannegieter, A.R. Hermus, G. van den Berg, A.M. Pereira, W.W. de Herder, M.A. Wagenmakers, M.N. Kerstens, P.M. Zelissen, E. Fliers, N. Schaper, M.L. Drent, O.M. Dekkers, V.E. Gerdes, Incidence of venous thromboembolism in patients with Cushing’s syndrome: a multicenter cohort study. J. Clin. Endocrinol. Metab. 96, 3525–3532 (2011)
13. R. Van der Pas, F.W.G. Leebeekt, L.J. Hofland, W.W. de Herder, R.A. Feelders, Hypercoaugulability in Cushing’s syndrome: prevalence, pathogenesis and treatment. Clinical. Endocrinol. 78, 481–488 (2013)
14. A.M. Isidori, M. Minnetti, E. Sbardella, C. Graziadio, A.B. Grossman, Mechanisms in endocrinology: the spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur. J. Endocrinol. 173, R101–R113 (2015)
15. C. Erem, I. Nuhoglu, M. Yilmaz, M. Kocak, A. Demirel, O. Ucuncu, H. Onder Ersoz, Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J. Endocrinol. Invest. 32, 169–174 (2009)
16. K. Martinod, D.D. Wagner, Thrombosis: tangled up in NETs. Blood 123, 2768–2776 (2014)
17. T.A. Fuchs, A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier, D.D. Myers Jr, S.K. Wrobleski, T.W. Wakefield, J.H. Hartwig, D.D. Wagner, Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. USA 107, 15880–15885 (2010)
18. F. Semeraro, C.T. Ammollo, N.L. Esmon, C.T. Esmon, Histones induce phosphatidylserine exposure and a procoagulant phenotype in human red blood cells. J. Thromb. Haemost. 12, 1697–1702 (2014)
19. F. Semeraro, C.T. Ammollo, J.H. Morrissey, G.L. Dale, P. Friese, N.L. Esmon, C.T. Esmon, Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118, 1952–1961 (2011)
20. C. Kannemeier, A. Shibamiya, F. Nakazawa, H. Trusheim, C. Ruppert, P. Markart, Y. Song, E. Tzima, E. Kennerknecht, M. Niepmann, M.L. von Bruehl, D. Sedding, S. Massberg, A. Günther, B. Engelmann, K.T. Preissner, Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc. Natl. Acad. Sci. USA 104, 6388–6393 (2007)
21. C.T. Ammollo, F. Semeraro, J. Xu, N.L. Esmon, C.T. Esmon, Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J. Thromb. Haemost. 9, 1795–1803 (2011)
22. J.A. Diaz, T.A. Fuchs, T.O. Jackson, J.A. Kremer Hovinga, B. Lämmle, P.K. Henke, D.D. Myers Jr, D.D. Wagner, T.W. Wakefield, for the Michigan Research Venous Group*. Plasma DNA is Elevated in Patients with Deep Vein Thrombosis. J. Vasc. Surg. Venous. Lymphat. Disord. 1, 341–348 (2013)
23. M.L. van Montfoort, F. Stephan, M.N. Lauw, B.A. Hutten, G.J. Van Mierlo, S. Solati, S. Middeldorp, J.C. Meijers, S. Zeerleder, Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler. Thromb. Vasc. Biol. 33, 147–151 (2013)
24. T.A. Fuchs, J.A. Kremer Hovinga, D. Schatzberg, D.D. Wagner, B. Lämmle, Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 120, 1157–1164 (2012)
25. J.I. Borissoff, I.A. Joosen, M.O. Versteylen, A. Brill, T.A. Fuchs, A.S. Savchenko, M. Gallant, K. Martinod, H. Ten Cate, L. Hofstra, H.J. Crijns, D.D. Wagner, B.L. Kietselaer, Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler. Thromb. Vasc. Biol. 33, 2032–2040 (2013)
26. H. Masri-Iraqi, E. Robenshtok, G. Tzvetov, Y. Manistersky, I. Shimon, Elevated white blood cell counts in Cushing’s disease: association with hypercortisolism. Pituitary 17, 436–440 (2014)
27. S. Ejaz, R. Vassilopoulou-Sellin, N.L. Busaidy, M.I. Hu, S.G. Waguespack, C. Jimenez, A.K. Ying, M. Cabanillas, M. Abbara, M.A. Habra, Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer 117, 4381–4389 (2011)
28. H.C. Hemker, P. Giesen, R. Al Dieri et al., Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol. Haemost. Thromb. 33, 4–15 (2003)
29. V. Chantarangkul, M. Clerici, C. Bressi et al., Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 88, 547–554 (2003)
30. Y. Dargaud, M.C. Trzeciak, J.C. Bordet, J. Ninet, C. Negrier, Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb. Haemost. 96, 562–567 (2006)
31. A. Tripodi, M. Primignani, V. Chantarangkul, A. Dell’Era, M. Clerici, R. de Franchis, M. Colombo, P.M. Mannucci, An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma from Patients with Cirrhosis. Gastroenterology 137, 2105–2111 (2009)
32. A. Tripodi, V. Chantarangkul, F. Gianniello, M. Clerici, L. Lemma, L. Padovan, L. Gatti, P.M. Mannucci, F. Peyvandi, Global coagulation in myeloproliferative neoplasms. Ann. Hematol. 92, 1633–1639 (2013)
33. S. Holdenrieder, P. Stieber, H. Bodenmueller, G. Fertig, H. Fürst, N. Schmeller, M. Untch, D. Seidel, Nucleosomes in serum as a marker for cell death. Clin. Chem. Lab. Med. 39, 596–605 (2001)
34. H. Parker, A.M. Albrett, A.J. Kettle, C.C. Winterbourn, Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J. Leukoc. Bio. 91, 369–376 (2012)
35. A. Tripodi, V. Chantarangkul, I. Martinelli, P. Bucciarelli, P.M. Mannucci, A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104, 3631–3634 (2004)
36. A. Tripodi, V. Chantarangkul, P.M. Mannucci, Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br. J. Haematol. 147, 77–82 (2009)
37. S. Koutroumpi, L. Spiezia, N. Albiger, M. Barbot, M. Bon, S. Maggiolo, S. Gavasso, P. Simioni, A. Frigo, F. Mantero, C. Scaroni, Thrombin generation in Cushing’s Syndrome: do the conventional clotting indices tell the whole truth? Pituitary 17, 68–75 (2014)
38. R. Swiatkowska-Stodulska, S. Kaniuka-Jakubowska, P. Wisniewski, A. Skibowska-Bielinska, K. Sworczak, The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing’s syndrome. Eur. J. Endocrinol. 165, 865–871 (2011)
39. C.R. Bishop, J.W. Athens, D.R. Boggs, H.R. Warner, G.E. Cartwright, M.M. Wintrobe, Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis. J. Clin. Invest. 47, 249–260 (1968)
40. G. Cox, Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154, 4719–4725 (1995)
41. D.C. Dale, A.S. Fauci, S.M. Wolff, Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N. Engl. J. Med. 291, 1154–1158 (1974)
42. M.L. von Brühl, K. Stark, A. Steinhart, S. Chandraratne, I. Konrad, M. Lorenz, A. Khandoga, A. Tirniceriu, R. Coletti, M. Köllnberger, R.A. Byrne, I. Laitinen, A. Walch, A. Brill, S. Pfeiler, D. Manukyan, S. Braun, P. Lange, J. Riegger, J. Ware, A. Eckart, S. Haidari, M. Rudelius, C. Schulz, K. Echtler, V. Brinkmann, M. Schwaiger, K.T. Preissner, D.D. Wagner, N. Mackman, B. Engelmann, S. Massberg, Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819–835 (2012)
43. C.B. Glaser, J. Morser, J.H. Clarke, E. Blasko, K. McLean, I. Kuhn, R.J. Chang, J.H. Lin, L. Vilander, W.H. Andrews, D.R. Light, Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J. Clin. Invest. 90, 2565–2573 (1992)
44. R. De Cristofaro, R. Landolfi, Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects. Thromb. Haemost. 83, 253–261 (2000)
45. S. Koutroumpi, V. Daidone, M.T. Sartori, M.G. Cattini, N.M. Albiger, G. Occhi, S. Ferasin, A. Frigo, F. Mantero, A. Casonato, C. Scaroni, Venous thromboembolism in patients with Cushing’s syndrome: need of a careful investigation of the prothrombotic risk profile. Pituitary 16, 175–181 (2013)
46. L. Manetti, F. Bogazzi, C. Giovannetti, V. Raffaelli, M. Genovesi, G. Pellegrini, L. Ruocco, A. Iannelli, E. Martino, Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing’s syndrome: results from a prospective study before and after surgery. Eur. J. Endocrinol. 163, 783–791 (2010)
47. P.A. Kyrle, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain, B. Schneider, A. Weltermann, W. Speiser, K. Lechner, S. Eichinger, High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N. Engl. J. Med. 343, 457–462 (2000)